 |
Page History
The following table describes the data elements displayed in the NCI As Sponsor Trials report for each trial:
| Data Element | Description | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| NCI ID | Identifier assigned to this trial by the CTRP. | ||||||||
Lead Organization | Name of the principal administrative organization responsible for this trial's research protocol. | ||||||||
Lead Organization Trial ID | Identifier assigned to this trial by the lead organization. | ||||||||
NCT ID | Identifier assigned to this trial by the National Clinical Trial program (ClinicalTrials.gov). | ||||||||
CTEP/DCP ID | Identifier assigned to this trial by the CTEP (Cancer Therapy Evaluation Program) or the DCP (Division of Cancer Prevention). | ||||||||
Sponsor | Name of the primary organization that oversees implementation of study and is responsible for data analysis. | ||||||||
Primary Completion Date | Date on which the final subject was examined or received an intervention, or the date on which that is expected to happen. | ||||||||
Primary Completion Date Type | Value indicating whether the completion date is the one on which the trial is expected to complete (Anticipated), or the date on which it actually completed (Actual). | ||||||||
Current Milestone | Value indicating the progress of the trial along its processing life cycle. For details, refer to Milestone Definitions and Recording Rules. | ||||||||
Milestone Date | Date on which the current milestone became effective. | ||||||||
The
| |||||||||
| Lead Org ID | The
| ||||||||
| Title | The
| ||||||||
| Lead Organization PO ID | The unique ID assigned to the lead organization by the CTRP. For information, refer to Abstracting Trial Descriptions, Titles, and Identifiers. | ||||||||
| Lead Organization | The
| ||||||||
| NCT ID | The
| ||||||||
| CTEP ID | The
| ||||||||
| DCP ID | The
| ||||||||
| Funding Mechanism | A
| ||||||||
| NCI Division/Program | The NCI division or program identified in an IND, IDE, or grant record, as the
| ||||||||
| Institution Code | The NIH institution associated with the trial, as identified in an IND, IDE, or grant record. For information, refer to NIH Institution Code Values, NIH Grant Institute Code Values, Abstracting INDs and IDEs, or Abstracting Funding. | ||||||||
| IND/IDE Grantor | The
For information, refer to Abstracting INDs and IDEs. | ||||||||
| IND/IDE Holder Type | The
For information, refer to Abstracting INDs and IDEs. | ||||||||
| IND/IDE Number | The
| ||||||||
| IND/IDE Types | A value indicating
| ||||||||
| Section 801 Indicator | A value indicating
| ||||||||
| Principal Investigator | The
| ||||||||
| Sponsor Org | The
| ||||||||
| Responsible Party | The
| ||||||||
| Summary 4 Funding Sponsor | The
| ||||||||
| Trial Status | The
| Current Trial Status | Current stage or state of a clinical trial or study relative to other stages and its ability to enroll participants/patients. For details | ||||||
| Trial Status Date | The
| ||||||||
Current Status Date | Date on which the current trial status became effective. | ||||||||
Record Verification Date | Date on which the abstracted data for the trial was verified. |
...
| hidden | true |
|---|
...
| |||||||
| Trial Start Date | The
| ||||||
| Primary Completion Date | The
| ||||||
| Primary Completion Date Type | A
| ||||||
| Submitting Org Name | The name of the organization that submitted the trial. | ||||||
| Current Processing Status | The
| ||||||
| Study Category | The
| ||||||
| Submission Number | A
| ||||||
| Trial Submission Type | A value indicating
| ||||||
| Trial Summary Report Sent Date | The date on which the system sent the Trial Summary Report (TSR) to the principal investigator or trial submitter. For information, refer to Processing Trial Milestones. |
